# Lung Cancer

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/lung-cancer/

## Facts

| Field | Value |
| --- | --- |
| APC (USD) | 3,110 |
| Citations | 344,430 |
| h-index | 186 |
| Homepage | http://www.elsevier.com/wps/find/journaldescription.cws_home/505953/description#description |
| Open Access | false |
| ISSN-L | 0169-5002 |
| ISSNs | 0169-5002,1872-8332 |
| OpenAlex ID | https://openalex.org/S100767427 |
| Publisher | Elsevier BV |
| Works | 27,476 |

## Journal papers

Showing 12 of 87.

- [Metastatic sites and survival in lung cancer](https://scholariq.org/papers/metastatic-sites-and-survival-in-lung-cancer/)
- [Reliability and validity of the functional assessment of cancer therapy—lung (FACT-L) quality of life instrument](https://scholariq.org/papers/reliability-and-validity-of-the-functional-assessment-of-cancer-therapy-lung/)
- [EGFR mutation detection in ctDNA from NSCLC patient plasma: A cross-platform comparison of leading technologies to support the clinical development of AZD9291](https://scholariq.org/papers/egfr-mutation-detection-in-ctdna-from-nsclc-patient-plasma-a-cross-platform/)
- [Endobronchial ultrasound guided transbronchial needle aspiration for staging of lung cancer](https://scholariq.org/papers/endobronchial-ultrasound-guided-transbronchial-needle-aspiration-for-staging-of-2/)
- [Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer—what limits limited disease?](https://scholariq.org/papers/staging-small-cell-lung-cancer-veterans-administration-lung-study-group-versus/)
- [Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab](https://scholariq.org/papers/correlation-between-immune-related-adverse-events-and-efficacy-in-non-small-cell/)
- [Nodule management protocol of the NELSON randomised lung cancer screening trial](https://scholariq.org/papers/nodule-management-protocol-of-the-nelson-randomised-lung-cancer-screening-trial/)
- [Pulmonary pleomorphic (spindle) cell carcinoma: peculiar clinicopathologic manifestations different from ordinary non-small cell carcinoma](https://scholariq.org/papers/pulmonary-pleomorphic-spindle-cell-carcinoma-peculiar-clinicopathologic/)
- [Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line](https://scholariq.org/papers/epithelial-to-mesenchymal-transition-derived-from-repeated-exposure-to-gefitinib/)
- [Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung cancer](https://scholariq.org/papers/randomized-phase-ii-study-of-first-line-carboplatin-paclitaxel-with-or-without/)
- [Clinical and molecular evidences of epithelial to mesenchymal transition in acquired resistance to EGFR-TKIs](https://scholariq.org/papers/clinical-and-molecular-evidences-of-epithelial-to-mesenchymal-transition-in/)
- [A comprehensive review of uncommon EGFR mutations in patients with non-small cell lung cancer](https://scholariq.org/papers/a-comprehensive-review-of-uncommon-egfr-mutations-in-patients-with-non-small/)

## Journal top topics

Showing 8 of 25.

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)
- [Radiomics and Machine Learning in Medical Imaging](https://scholariq.org/topics/radiomics-and-machine-learning-in-medical-imaging/)
- [Occupational and environmental lung diseases](https://scholariq.org/topics/occupational-and-environmental-lung-diseases/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cancer therapeutics and mechanisms](https://scholariq.org/topics/cancer-therapeutics-and-mechanisms/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.